Topics & News
-
Takanori ABE gave a speech entitled "A new drug pricing system reform proposal in Japan - To balance setting the upper limit of total drug expenditure with appropriate evaluation of the value of innovative drugs" at LSPN Connect.
-
Takanori ABE gave a speech at the session "Trade secret and punitive damages in IP" at APABA Silicon Valley.
-
Takanori ABE gave a speech entitled "Why the first penguin of Pay for Delay has not come in Japan-Anatomy of the Japanese Paradox-" at LSPN Connect.
-
Takanori ABE's article titled "Directors’ liability for patent infringement pursuant to the Companies Act" had been published on Managing Intellectual Property Magazine (WINTER 2021).
-
Takanori ABE published the article titled "Directors’ liability for patent infringement pursuant to the Companies Act".
-
open_in_newTakanori ABE gave a speech entitled "SEP and Automotive Industry in Japan" at the session "The Role of SEPs for the Automotive Industry" at IP Watchdog's STANDARD ESSENTIAL PATENTS 2021.
-
Takanori ABE gave a speech entitled "Clinical trials for original drugs fall under experimental use exception" at LSPN Connect.
-
Takanori ABE gave a speech entitled "Clinical trials for original drugs fall under experimental use exception" at the client company (a pharmaceutical company).
-
Takanori ABE gave a speech entitled "A closer look at Japan’s desirable patent system in the era of COVID-19" at KTK.
-
Takanori ABE gave a speech entitled "Function or Sequence? Antibody Patents in Japan after Baxalta v. Chugai/Amgen v. Sanofi." at LSPN Connect.
-
open_in_newTakanori ABE gave a speech entitled "Patenting Antibodies - Antibody Patents in Japan after Baxalta v. Chugai/Amgen v. Sanofi- Function or Sequence?" at IP Life Sciences Conference.
-
open_in_newTakanori ABE gave a speech entitled "Patenting Antibodies - Antibody Patents in Japan after Baxalta v. Chugai/Amgen v. Sanofi- Function or Sequence?" at LSPN Connect Live.
-
ABE & PARTNERS represented Japanese Corporation Y against U.S. Corporation X in the U.S. patent case and resolved by settlement.
-
open_in_newTakanori ABE gave a speech at the session "What Does the Future Hold for Reverse-Payment Settlement Litigation, Patent Thicketing and Restrictive Distribution Agreements?" at ACI’s premiere conference on Life Sciences Antitrust.
-
Takanori ABE was appointed as a national expert for the pharmaceutical legislation in Japan by the European Commission DG SANTE to provide a national report.
-
ABE & PARTNERS represented Japanese Corporation Y against U.S. Corporation X in the U.S. patent case and resolved by settlement.
-
Takanori ABE's article titled "A new drug pricing system reform proposal in Japan" was ranked No. 2 of Most Read Article on Life Sciences Intellectual Property Review.
-
Takanori ABE published the article titled "A new drug pricing system reform proposal in Japan".
-
open_in_newTakanori ABE's article titled "A new drug pricing system reform proposal in Japan" had been published on Life Sciences Intellectual Property Review.
-
Takanori ABE's article titled "Will Authorised Biologics deter Biosimilars? - Utilising JFTC's expertise in drug pricing -" had been published on Fair Trade Magazine (August 2021).
-
Takanori ABE published the article titled "Assessing the licensing environment of SEPs in Japan".
-
Takanori ABE's article titled "Assessing the licensing environment of SEPs in Japan" had been published on Managing Intellectual Property Magazine (SUMMER 2021).
-
Takanori ABE published the article titled "Clinical trials for original drugs fall under experimental use exception".
-
Takanori ABE's article titled "Clinical trials for original drugs fall under experimental use exception" had been published on LSPN Connect.
-
Takanori ABE published the article titled "A closer look at Japan’s desirable patent system in the era of COVID-19".
-
Takanori ABE has been selected as Top 50 IP Experts of Japan 2021 by Asia IP.
-
Takanori ABE published the article titled "The strategic acquisition and utilisation of SEPs: reviewing Japan’s IP Promotion Plan 2021".
-
Takanori ABE's article titled "The strategic acquisition and utilisation of SEPs: reviewing Japan’s IP Promotion Plan 2021" had been published on Managing Intellectual Property Magazine (SUMMER 2021).
-
Takanori ABE published the article titled "U.S. Patent Litigation Update : The Resurgence of Patent Trolls".
-
open_in_newTakanori ABE gave a speech at the session "Antibody Patents After Amgen v. Sanofi" at ACI’s 19th Global Summit on Life Sciences Patents.
-
Takanori ABE's article titled "A closer look at Japan’s desirable patent system in the era of COVID-19" had been published on Managing Intellectual Property Magazine (SUMMER 2021).
-
ABE & PARTNERS held a seminar "U.S. Patent Litigation Update: The Resurgence of Patent Trolls" jointly with Akin Gump Strauss Hauer & Feld LLP.
-
open_in_newABE & PARTNERS has been ranked Tier2 in Japan Domestic, Patents by Asian Legal Business' ASIA IP Rankings 2021.
-
Takanori ABE published the article titled "Reviewing the JPO’s Hantei (Advisory Opinion) for Essentiality Check".
-
Takanori ABE's article titled "Reviewing the JPO’s Hantei (Advisory Opinion) for Essentiality Check" had been published on Managing Intellectual Property Magazine (SUMMER 2021).
-
open_in_newTakanori ABE gave a lecture entitled "New IP Mediation Proceedings, New Inspection System" at the seminar organized by Research Institute of Economy, Trade and Industry.
-
Takanori ABE gave a lecture entitled "Medical Standard of Care" at Faculty of Medicine, Osaka University.
-
open_in_newTakanori ABE gave a speech entitled "How was Japanese patent litigation reformed?" at 9th edition of World IP Forum.
-
Takanori ABE has been selected as IP Star 2021 by Managing Intellectual Property.
-
ABE & PARTNERS represented X Corporation against Y Corporation in the patent case and resolved by settlement.
-
Takanori ABE's article titled "Damages awarded based on LED-equipped TV for LED patent infringement" had been published on Managing Intellectual Property Magazine (SUMMER 2021).
-
Takanori ABE published the article titled "Damages awarded based on LED-equipped TV for LED patent infringement".
-
Takanori ABE's article titled "Courts rule on likelihood of confusion in medical device case" had been published on Managing Intellectual Property Magazine (WINTER 2020).
-
Takanori ABE published the article titled "Courts rule on likelihood of confusion in medical device case".
-
Takanori ABE's article appeared in an article titled "Matsukiyo-Cocokara merger to create leading drugstore will benefit from regulatory changes" in PaRR.
-
open_in_newTakanori ABE gave a speech entitled "Complying with Licesing and Product Requirements" at the 8th Annual Conference on Cosmetics & Personal Care Products.
-
Takanori ABE's article appeared in an article titled "Japanese government launches SEP advisory panel with renewed focus on competition" in PaRR.
-
Takanori ABE gave a lecture entitled "How was Japanese patent litigation reformed?"at the client company (an information technology company).
-
Takanori ABE's comment appeared in an article titled "Utilizing mediation in patent dispute" in Nikkei Newspaper.
-
Takanori ABE published the article titled "Antimonopoly Act defence proves successful against patent enforcement".
Archive